GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pacira BioSciences Inc (FRA:82P) » Definitions » Cyclically Adjusted Book per Share

Pacira BioSciences (FRA:82P) Cyclically Adjusted Book per Share : €10.91 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Pacira BioSciences Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Pacira BioSciences's adjusted book value per share for the three months ended in Mar. 2024 was €17.645. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €10.91 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Pacira BioSciences's average Cyclically Adjusted Book Growth Rate was 20.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 25.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 57.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Pacira BioSciences was 93.30% per year. The lowest was 25.50% per year. And the median was 52.70% per year.

As of today (2024-05-19), Pacira BioSciences's current stock price is €28.60. Pacira BioSciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €10.91. Pacira BioSciences's Cyclically Adjusted PB Ratio of today is 2.62.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pacira BioSciences was 59.96. The lowest was 2.21. And the median was 9.00.


Pacira BioSciences Cyclically Adjusted Book per Share Historical Data

The historical data trend for Pacira BioSciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacira BioSciences Cyclically Adjusted Book per Share Chart

Pacira BioSciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.30 4.55 6.80 8.79 10.07

Pacira BioSciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.96 9.41 10.19 10.07 10.91

Competitive Comparison of Pacira BioSciences's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Pacira BioSciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacira BioSciences's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pacira BioSciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pacira BioSciences's Cyclically Adjusted PB Ratio falls into.



Pacira BioSciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pacira BioSciences's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=17.645/131.7762*131.7762
=17.645

Current CPI (Mar. 2024) = 131.7762.

Pacira BioSciences Quarterly Data

Book Value per Share CPI Adj_Book
201406 3.039 100.560 3.982
201409 3.341 100.428 4.384
201412 3.839 99.070 5.106
201503 4.679 99.621 6.189
201506 4.753 100.684 6.221
201509 5.069 100.392 6.654
201512 5.441 99.792 7.185
201603 5.474 100.470 7.180
201606 5.452 101.688 7.065
201609 5.106 101.861 6.606
201612 5.539 101.863 7.166
201703 6.322 102.862 8.099
201706 5.762 103.349 7.347
201709 5.477 104.136 6.931
201712 5.807 104.011 7.357
201803 5.547 105.290 6.942
201806 6.072 106.317 7.526
201809 6.288 106.507 7.780
201812 6.850 105.998 8.516
201903 7.020 107.251 8.625
201906 7.267 108.070 8.861
201909 7.537 108.329 9.168
201912 7.623 108.420 9.265
202003 8.037 108.902 9.725
202006 8.089 108.767 9.800
202009 11.461 109.815 13.753
202012 11.673 109.897 13.997
202103 12.437 111.754 14.665
202106 12.835 114.631 14.755
202109 13.719 115.734 15.621
202112 14.450 117.630 16.188
202203 14.297 121.301 15.532
202206 15.628 125.017 16.473
202209 16.959 125.227 17.846
202212 15.930 125.222 16.764
202303 15.605 127.348 16.148
202306 16.069 128.729 16.449
202309 16.783 129.860 17.031
202312 17.166 129.419 17.479
202403 17.645 131.776 17.645

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Pacira BioSciences  (FRA:82P) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Pacira BioSciences's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=28.60/10.91
=2.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pacira BioSciences was 59.96. The lowest was 2.21. And the median was 9.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Pacira BioSciences Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Pacira BioSciences's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacira BioSciences (FRA:82P) Business Description

Traded in Other Exchanges
Address
5401 West Kennedy Boulevard, Suite 890, Tampa, FL, USA, 33609
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.

Pacira BioSciences (FRA:82P) Headlines

No Headlines